Drug-induced endocrine blood pressure elevation

Katharina R. Beck, George R. Thompson, Alex Odermatt

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

Patients with uncontrolled hypertension are at risk for cardiovascular complications. The majority of them suffers from unidentified forms of hypertension and a fraction has so-called secondary hypertension with an identifiable cause. The patient's medications, its use of certain herbal supplements and over-the-counter agents represent potential causal factors for secondary hypertension that are often overlooked. The current review focuses on drugs that are likely to elevate blood pressure by affecting the human endocrine system at the level of steroid synthesis or metabolism, mineralocorticoid receptor activity, or by affecting the catecholaminergic system. Drugs with known adverse effects but where benefits outweigh their risks, drug candidates and market withdrawals are reviewed. Finally, potential therapeutic strategies are discussed.

Original languageEnglish (US)
Article number104311
JournalPharmacological Research
Volume154
DOIs
StatePublished - Apr 2020
Externally publishedYes

Keywords

  • 11beta-hydroxysteroid dehydrogenase
  • Abiraterone
  • Adverse drug reaction
  • Carbenoxolone
  • Catecholamine
  • Danazol
  • Etomidate
  • Hypertension
  • Itraconazole
  • Ketoconazole
  • Lisdexamphetamine
  • Metyrapone
  • Mifepristone
  • Mineralocorticoid excess
  • Posaconazole
  • Steroidogenesis

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Drug-induced endocrine blood pressure elevation'. Together they form a unique fingerprint.

  • Cite this